Search Results - "Cointe, Aurélie"

Refine Results
  1. 1

    Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review by Joseph, Adrien, Cointe, Aurélie, Mariani Kurkdjian, Patricia, Rafat, Cédric, Hertig, Alexandre

    Published in Toxins (21-01-2020)
    “…The severity of human infection by one of the many Shiga toxin-producing (STEC) is determined by a number of factors: the bacterial genome, the capacity of…”
    Get full text
    Journal Article
  2. 2

    Fatal Meningitis from Shiga Toxin-Producing Escherichia coli in 2 Full-Term Neonates, France by Geslain, Guillaume, Cointe, Aurélie, Bidet, Philippe, Courroux, Céline, Abasse, Soumeth, Mariani, Patricia, Bonacorsi, Stéphane

    Published in Emerging infectious diseases (01-08-2023)
    “…We report fatal meningitis in 2 neonates in France caused by Shiga toxin 1-producing Escherichia coli. Virulence factors capsular K1 antigen and salmochelin…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Sporadic Shiga Toxin–Producing Escherichia coli –Associated Pediatric Hemolytic Uremic Syndrome, France, 2012–2021 by Jones, Gabrielle, Mariani-Kurkdjian, Patricia, Cointe, Aurelie, Bonacorsi, Stephane, Lefevre, Sophie, Weill, Francois-Xavier, Le Strat, Yann

    Published in Emerging infectious diseases (01-10-2023)
    “…Shiga toxin–producing Escherichia coli–associated pediatric hemolytic uremic syndrome (STEC-HUS) remains an important public health risk in France. Cases are…”
    Get full text
    Journal Article
  5. 5

    Detection of Carbapenemase-Producing Enterobacteriaceae in Positive Blood Culture Using an Immunochromatographic RESIST-4 O.K.N.V. Assay by Cointe, Aurélie, Bonacorsi, Stéphane, Truong, Jeanne, Hobson, Claire, Doit, Catherine, Monjault, Audrey, Bidet, Philippe, Birgy, André

    Published in Antimicrobial agents and chemotherapy (01-12-2018)
    “…We evaluated the performance of the RESIST-4 O.K.N.V. assay (Coris) with 98 isolates to detect OXA-48-like and KPC-, NDM-, and VIM-type carbapenemases directly…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management by Travert, Benoit, Rafat, Cédric, Mariani, Patricia, Cointe, Aurélie, Dossier, Antoine, Coppo, Paul, Joseph, Adrien

    Published in Toxins (26-04-2021)
    “…Shiga toxin-producing -associated hemolytic uremic syndrome (STEC-HUS) is a form of thrombotic microangiopathy secondary to an infection by an…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Emergence of New ST301 Shiga Toxin-Producing Escherichia coli Clones Harboring Extra-Intestinal Virulence Traits in Europe by Cointe, Aurélie, Bizot, Etienne, Delannoy, Sabine, Fach, Patrick, Bidet, Philippe, Birgy, André, Weill, François-Xavier, Lefèvre, Sophie, Mariani-Kurkdjian, Patricia, Bonacorsi, Stéphane

    Published in Toxins (26-09-2021)
    “…O80:H2 enterohemorrhagic (EHEC) of sequence type ST301 is one of the main serotypes causing European hemolytic and uremic syndrome, but also invasive…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Contribution of Serological Rapid Diagnostic Tests to the Strategy of Contact Tracing in Households Following SARS-CoV-2 Infection Diagnosis in Children by Charbonnier, Lorelei, Rouprêt-Serzec, Julie, Caseris, Marion, Danse, Marion, Cointe, Aurélie, Cohen, Laure, Faye, Albert, Ouldali, Naïm, Gaschignard, Jean

    Published in Frontiers in pediatrics (10-05-2021)
    “…Background: The contact tracing and isolation of contagious individuals are cornerstones in the control of the COVID-19 pandemic. Strategies to identify…”
    Get full text
    Journal Article
  14. 14

    Cross-resistance to cefiderocol and ceftazidime–avibactam in KPC β-lactamase mutants and the inoculum effect by Hobson, Claire Amaris, Cointe, Aurélie, Jacquier, Hervé, Choudhury, Alaksh, Magnan, Mélanie, Courroux, Céline, Tenaillon, Olivier, Bonacorsi, Stéphane, Birgy, André

    Published in Clinical microbiology and infection (01-08-2021)
    “…Ceftazidime–avibactam (CZA) and cefiderocol are recently commercialized molecules active against highly drug-resistant bacteria, including carbapenem-resistant…”
    Get full text
    Journal Article
  15. 15

    Tuberculosis in Children Hospitalized in a Low-burden Country: Description and Risk Factors of Severe Disease by Cogo, Haude, Caseris, Marion, Lachaume, Noémie, Cointe, Aurélie, Faye, Albert, Pommelet, Virginie

    Published in The Pediatric infectious disease journal (01-03-2021)
    “…In high-income countries, few pediatric studies have described the clinical expression of tuberculosis (TB) according to age, and their results are discordant…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20